Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank71
5Y CAGR-26.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-26.2%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 36.01% |
| 2024 | 23.29% |
| 2023 | 61.83% |
| 2022 | -19.81% |
| 2021 | 439.98% |
| 2020 | 164.92% |
| 2019 | -72.57% |
| 2018 | -136.93% |
| 2017 | 366.07% |
| 2016 | -35.87% |